Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$506.34 USD
+2.50 (0.50%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$506.34 USD
+2.50 (0.50%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth B Momentum C VGM
Zacks News
Intuitive Surgical (ISRG) Upbeat on Q4 & 2017 Sales Results
by Zacks Equity Research
Intuitive Surgical (ISRG) optimistic about fourth-quarter and 2017 net sales outcome on revenue growth across all business segments.
The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Macy???s, Target, SS&C Technologies, Intuitive Surgical and Brighthouse Financial
Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors
by Zacks Equity Research
Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.
Hill-Rom (HRC) Estimates Strong Revenue Figures for Q1
by Zacks Equity Research
Hill-Rom (HRC) expects substantial tax savings from the recent U.S. tax reform.
Buy These 3 Stocks on Today's Strong Gains
by Benjamin Rains
The New Year has been dominated by cryptocurrencies and blockchain technology, with unlikely companies such as Kodak (KODK) jumping on the bandwagon after announcing its new KODAKCoin and KODAKOne platform.
NuVasive Q4 Preliminary Results Fail to Cheer Investors
by Zacks Equity Research
NuVasive (NUVA) continues to witness sequential growth in international revenues and expects substantial tax savings from the recent U.S. tax reform.
DexCom Estimates Strong Revenue Figures for Q4 and 2017
by Zacks Equity Research
Dexcom (DXCM) to gain from strong sensor volumes, international revenues and expanding worldwide patient base in 2018.
RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries
by Zacks Equity Research
RTI Surgical (RTIX) to integrate Zyga's SImmetry Sacroiliac Joint Fusion System to diversify Spine franchise.
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
by Zacks Equity Research
Zimmer Biomet's (ZBH) Sidus Stem-Free Shoulder system offers a minimal bone resection in total shoulder arthroplasty, which the company claims to help reduce pain and restore a range of motions.
McKesson Buys RxCrossroads from CVS Health for $735 Million
by Zacks Equity Research
McKesson (MCK) has been actively pursuing deals, divestitures and acquisitions to drive growth. The latest buyout will boost Specialty Health business.
Walgreens Boots (WBA) Tops Q1 Earnings, Margins Decline
by Zacks Equity Research
Walgreens Boots (WBA) surpasses the Zacks Consensus Estimate for both the counts in Q1 on continued prescription growth and strength in the Retail Pharmacy USA division.
Neogen (NEOG) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Neogen (NEOG) rides high on balanced growth across all business segments in Q2.
Stryker's Global Foothold Strong Amid Product Recall Issue
by Zacks Equity Research
Stryker (SYK) enjoys strong foothold in the European and Australian markets. On the flip side, the company witnesses lower demand for health care products.
5 Reasons Why You Should Buy Abiomed (ABMD) Stock Right Now
by Zacks Equity Research
Abiomed (ABMD) gains from solid product portfolio. Also, impressive performance on the bourses instills investor's optimism on the stock.
Intuitive Surgical Banks on da Vinci X, Forex Woes Remain
by Zacks Equity Research
Intuitive Surgical's (ISRG) consistent efforts to boost da Vinci X platform is a positive. However, foreign exchange movements are impacting the company's results
Top Stock Reports for Nike, PayPal & BNY Mellon
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Nike (NKE), PayPal (PYPL) and BNY Mellon (BK).
Intuitive Surgical Hits a 52-Week High on Solid Prospects
by Zacks Equity Research
The market is upbeat about Intuitive Surgical's (ISRG) solid procedure performance in Asia, with growth in China, Japan and Korea.
Why Is Intuitive Surgical (ISRG) Up 9.8% Since the Last Earnings Report?
by Zacks Equity Research
Intuitive Surgical (ISRG) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Baxter International, BostonScientific, Intuitive Surgical and Becton and Dickinson
Trump Focuses on APAC: 4 MedTech Stocks to Watch
by Zacks Equity Research
Considering Trump's growing focus on APAC, the region seems to be poised to yield accretive returns over the long term. Favorable MedTech trends in APAC hold promise.
Intuitive Surgical (ISRG) to Gain From Procedural Business
by Zacks Equity Research
Intuitive Surgical's (ISRG) sales to gain from on da Vinci system and procedural growth in general surgery, oncology, urology and gynecology.
Are Options Traders Betting on a Big Move in Intuitive Surgical (ISRG) Stock?
by Zacks Equity Research
Investors in Intuitive Surgical (ISRG) need to pay close attention to the stock based on moves in the options market lately.
The Zacks Analyst Blog Highlights: Activision, Marriott, Intuitive Surgical, Edison International and TELUS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Activision, Marriott, Intuitive Surgical, Edison International and TELUS
Weight Watchers (WTW) to Issue $500M Senior Notes Due 2025
by Zacks Equity Research
Weight Watchers' (WTW) plan to issue senior notes will aid the company in reducing cost of capital.
Top Stock Reports for Activision, Marriott & Intuitive Surgical
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Activision (ATVI), Marriott (MAR) and Intuitive Surgical (ISRG).